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ABSTRACT
The mucosal pathogen Chlamydia trachomatis affects hundreds of millions of people worldwide and
is a significant cause of sexually transmitted disease. Although most acute infections can be easily
managed, complications often occur that can be especially severe in women. It has been proposed
that increased exposure to conserved chlamydial antigens, such as through reinfection or persistent
infection, results in chronic inflammation and tissue scarring and contributes to the pathogenesis of
endometrial and fallopian tube damage. This immunopathologic damage is believed to be a principal
cause of ectopic pregnancy and tubal factor infertility. The chlamydial heat shock protein Hsp60,
a homolog of Escherichia coli GroEL, has been identified as one protein capable of eliciting intense
mononuclear inflammation. Furthermore, several studies have revealed a correlation between
Hsp60 responses and the immunopathologic manifestations ofhuman chlamydial disease. The role
of additional antigens in the immunopathologic response to chlamydiae is currently undefined. A
prime candidate, however, is the chlamydial GroES homolog Hspl0, which is genetically and
physiologically linked to Hsp60. Recent studies provide data to suggest that immune reactivity to
Hspl0 is significantly associated with tubal infertility in a chlamydiae-exposed population. Chla-
mydia pneumoniae is a more recently defined chlamydial species that has been implicated in a variety
of ways with chronic disease processes, such as adult onset asthma and atherosclerosis. Evidence
indicates that Hsp60 is present in human atheroma and may play a role in lesion development by
direct activation of macrophages. Hsp60 causes the elaboration of inflammatory cytokines, the
induction of metalloproteinase, and the oxidation of low density lipoprotein. Each of these events is
directly associated with the progress of atherosclerosis. Thus, chlamydial heat shock proteins may
function in at least two ways to promote chronic disease: first by direct antigenic stimulation and
second as signal transducers that result in macrophage activation. These concepts in disease pa-
thology are discussed in the context of chlamydial infections. Infect. Dis. Obstet. Gynecol. 7:64-71,
1999. (C) 1999 Wiley-Liss, Inc.
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BACKGROUND
Ch/amydiae are unique prokaryotic organisms. They
not only are restricted to an obligate intracellular
existence within the confines of a membrane-
bound vesicle (inclusion) in the cytoplasm of sus-
ceptible host cells, but also they undergo morpho-
logic, biochemical, and physiologic changes during
the course of their intracellular existence. Produc-
tive chlamydial growth involves host cell invasion
by the environmentally stable elementary body
(EB) followed by differentiation to the metaboli-
cally active reticulate body (RB). Growth and rep-
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lication of RB then proceeds by binary fission. The
cycle is completed when the greatly expanded
number of RBs differentiate back to EB and are
released to infect new susceptible host cells. How-
ever, chlamydial growth as it exists during actual
infections may include additional growth options
that extend the definition of intracellular chlamyd-
ial development to choices beyond orderly transi-
tions between EB and RB. Cell culture studies1-4
and observations in vivos-8 demonstrate that chla-
mydial growth may manifest in a whole spectrum
of interesting and novel ways. For example, Moul-
der et al.9 identified a cryptic form of chlamydial
existence that may serve to perpetuate these or-
ganisms intracellularly in an unrecognizable form
for extended periods of time. Similarly, intracellu-
lar RB may be induced to enter a nonreplicative,
noninfectious stage of development that estab-
lishes a persistent, long-term relationship with the
infected host cell that in some respects duplicates
events that can be associated with chronic chla-
mydial infections. This nonproductive growth
stage has been termed persistence and is charac-
terized as a form of stressed growth, since stress-
response proteins such as the heat shock protein
(hsp) Hsp60 are produced in greatly elevated
amounts, compared with structural proteins, when
chlamydiae are in this developmental state. The
full range of stimuli that can cause chlamydiae to
enter the persistent state are not definitively
known, but host cell activation by immune regu-
lated cytokines and growth at elevated (39-42C)
temperatures appear to be two physiologically rel-
evant stress-related conditions that can trigger per-
sistence. In addition, persistence does not appear
to be an irreversible process, since removal of in-
ducing stimuli results in resumption of productive
growth. In vivo evidence for chlamydial persis-
tence has come from clinical conditions as diverse
as arthritis,s upper genital tract infections,6 tra-
choma,7 Alzheimer disease,8 and atherosclerosis.1
An important correlate of persistence and the dis-
ease process caused by chlamydiae involves the
production of stress-response proteins during per-
sistent growth. Chlamydial stress-response proteins
have been associated with the pathologic conse-
quences of chronic chlamydial diseases and provide
the focal point for data and experimental systems
reviewed here.
CHLAMYDIA TRACHOMATIS, HEAT
SHOCK PROTEINS, AND UPPER
GENITAL TRACT INFECTIONS
IN WOMEN
Chlamydia trachomatis remains one of the most
prevalent human microbial pathogens. This obli-
gate intracellular bacterium is responsible for more
than 4 million cases of sexually transmitted infec-
tions in the United States per year.1 Though the
majority of these cases will be uncomplicated acute
or asymptomatic infections for either men or
women, about one in 10 women with inadequately
treated or unrecognized cervicitis will progress to
an upper genital tract infection such as salpingitis
and pelvic inflammatory disease (PID).z The con-
sequences of these ascending complications can be
severe. Chronic inflammation and subsequent fal-
lopian tube scarring greatly increase the risk of ec-
topic pregnancy and tubal factor infertility (TFI).z
However, the manner by which endometrial and
tubal damage accumulates in chlamydial upper
genital tract disease has not been precisely defined.
It is thought that antigens that are conserved
among the various C. trachomatis serovars are im-
portant in eliciting these chronic inflammatory re-
sponses, since there is no evidence that immuno-
pathologic potential is related to one or a subset of
infecting chlamydial serovars. 3,14 Repeated or con-
tinuous exposure to these antigens, such as through
one or more reinfections or the development of
persistent low-level chlamydial growth, may ulti-
mately be the catalyst for immunopathologic de-
velopment.
Precise identification of those chlamydial anti-
gens that may participate in the immunopathologic
response is an area of active investigation. Chla-
mydial hsps have been pursued as major players
involved in human immune pathology as a result of
several key studies that made associations between
responses to the chlamydial GroEL homolog
Hsp60 and the sequelae of upper genital tract dis-
ease including ectopic pregnancy,s chronic pelvic
pain, 6,17 perihepatitis,
8 and TFI. 19-z Antibody
responses in particular have been used to show an
increased frequency of seropositivity to chlamydial
antigens among patients with immunopathologic
sequelae when compared with appropriate con-
trols. Though these studies may imply some level
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of connection, the causal mechanism by which the
damage occurs remains poorly understood.
There have been several theories about how
chlamydial hsps may elicit immune pathology.
Work with animal models has identified Hsp60 as
an antigen capable of eliciting profound inflamma-
tion characteristic of delayed-type hypersensitivity
(DTH).zz,z3 In a model of ocular chlamydial immu-
nopathology, Morrison et al.zz showed that purified
Hsp60 triggered an immunopathologic response in
sensitized animals that was histologically and clini-
cally comparable to chronic chlamydial disease.
Chlamydial lipopolysaccharide (LPS), a genus-
specific antigen, and the major outer membrane
protein (MOMP) did not elicit such responsesz4,zs
in this model. Hsp60 has also been shown to elicit
DTH responses in genital tract tissue of sensitized
animals, resulting in more severe disease,z3 From
these observations, a model of T-cell-mediated de-
velopment of chlamydial immunopathology was
proposed in which individuals who become sensi-
tized by repeated or persistent exposure to Hsp60
developed a chronic mononuclear inflammation re-
suiting in scarring and subsequent tissue damage.
Fine specificity analysis of the epitopes recog-
nized by the immune response of women with se-
vere upper genital tract disease led to the proposal
that an autoimmune etiology of immunopathologic
damage may be at work. Witkin et al.z6 showed
that T cells from four out of 10 patients with re-
current salpingitis reacted to a peptide from a con-
served region of Hsp60, while neither patients with
first-episode salpingitis nor healthy controls recog-
nized the cross-reactive epitope. Further research
has shown that patients with advanced upper geni-
tal tract disease 16 and sequelae is,z7 have antibodies
to certain epitopes on chlamydial Hsp60 that could
cross-react with epitopes on the human homologue
of Hsp60. Since chlamydial Hsps share significant
homology with mammalian homologues, zz,z8
chronic or repeated exposure to these antigens may
break immunological tolerance and lead to tissue
damage.
Alternatively, an alteration of the local immune
response to chlamydial hsps may promote immune
pathology. Holland et al.z9 have shown a depressed
Thl response among patients with trachoma. Since
Thl responses are noted to produce interferon-
gamma, which inhibits chlamydial growth, perhaps
this reduced capacity allows chlamydiae to escape
eradication and persist at low levels at the site of
developing immune pathology. Also, changes in in-
flammatory cytokines such as tumor necrosis fac-
tor-or and transforming growth factor-[3 may ad-
versely affect the progression of the local immune
response.3-3z Whether by sensitization, epitopes
recognized, or cytokines elaborated, the underlying
theme to these theories seems to be that there is
some fundamental difference in the immune re-
sponse to chlamydial hsps between patients with
and without immunopathology that is responsible
for the development of damage. In any case, none
of the above is necessarily mutually exclusive, and
multiple mechanisms of tissue damage may take
effect during different stages of pathological devel-
opment.
While we know best the potential for chlamydial
Hsp60 to cause inflammation and to be associated
with chronic disease sequelae, there may be addi-
tional conserved chlamydial antigens that contrib-
ute independently or synergistically to the devel-
opment of tissue damage. Though Hsp60 is cer-
tainly a clear immunopathology-associated
antigen,4 in general, little is known about the ca-
pacity of other chlamydial proteins to induce DTH
or autoimmune responses. Reports on the immu-
nogenicity of hsp antigens from other microbial
pathogens in the context of human disease have
provided insight to pursue a second putative im-
munopathologic antigen. The Mycobacterium leprae
and Mycobacterium tuberculosis homologues of
Hspl0, members of the GroES family of proteins,
have been shown to be prominent T-cell antigens
and targets of serum antibody responses.
3-6 My-
cobacterial Hspl0 induces T-cell-mediated hyper-
sensitivity in infected individuals and sensitized
animals.6-’9 Since Hspl0 homologues are geneti-
cally and physiologically linked with Hsp60 homo-
logues, the chlamydial Hspl0 became a prime can-
didate for investigation.
Until recently, the antigenicity of chlamydial
Hsp 10 had not been investigated mainly due to the
lack of purified protein and suitable antibody re-
agents for analysis. We have cloned and purified
the Hspl0 from the common genital tract infec-
tion-associated serovar E of C. trachomatis4 and
have employed it in a series of assays to evaluate its
potential to be immunopathogenic. To accomplish
this, we initiated an approach not unlike the early
Hsp60 serological investigations. In our current re-
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TABLE I. Comparison of the frequency of seropositive individuals by group and subgroup
Significantly more women seropositive for
Group Hspl0 Hsp60 MOMP
Acutely infected women, compared to uninfected controls
Women with TFI, compared to uninfected controls
Are more women with TFI seropositive than acutely infected women?
For EB+ patients only, are more women with TFI seropositive than
acutely infected women?







aComparison of the number of positive serological responses in each indicated group or subgroup. A patient is scored seropositive if that patient’s
antigen-specific ELISA absorbance is greater than the mean plus two standard deviations of the control uninfected population. Significant differences
determined by Fisher’s exact test.
search, we are investigating whether a serological
correlation exists between Hsp 10 exposure and the
immune sequelae of TFI. We hypothesize that
among patients with evidence of prior chlamydial
infection, those that exhibit tubal immunopathol-
ogy would be more likely to have an immune re-
sponse to Hspl0 than women with simple acute
infections or uninfected healthy controls.
We have been able to establish several basic
parameters about the immune response to chla-
mydial Hspl0. First, chlamydial Hspl0 was iden-
tified for the first time as a target of the immune
response made by women with prior chlamydial
exposure. Both women with active infections and
women with TFI recognized Hspl0 more fre-
quently than healthy uninfected women (Table 1).
Of more significance, those women with TFI rec-
ognized Hspl0 more frequently than the actively
infected women. The same pattern is seen when
comparing the amount of antigen-specific antibody
present in the serum of these women (Table 2).
Thus, women with TFI recognize Hspl0 more of-
ten and to a greater degree than either actively
infected women or healthy uninfected women.
This may reflect increased exposure to Hspl0
through repeated or persistent chlamydial infec-
tion. An interesting observation was made when
each group was subdivided on the basis of serore-
activity to whole chlamydiae, and EB+ subgroups
were analyzed separately from EB- subgroups.
The association of Hspl0 reactivity with TFI
among the EB+ subgroup became more significant,
while associations among the EB- subgroup be-
came insignificantly different from controls. This
may indicate that chlamydiae-specific rather than
cross-reactive epitopes of Hspl0 are associated
with TFI. Taken together, these findings support
the hypothesis that immunological exposure to C.
trachomatis hsps is associated with TFI and identi-
fies Hsp10 as an antigen recognized by a significant
proportion of women with TFI. As has been pro-
posed for Hsp60, Hspl0 reactivity may also con-
tribute to the immunopathologic manifestations of
severe upper genital tract complications of chla-
mydial disease in women. This study also points
out that further research is warranted to more pre-
cisely define the potential contribution of Hspl0




Chlamydial Hsp60 has not only been associated
with disease severity in chronic sequelae of C. tra-
chomatis infections, but also has recently been lo-
calized to human atheromatous tissue1 and asso-
ciated with the development of atherosclerosis and
atherosclerotic disease by several important crite-
ria. This is a significant observation since C. pneu-
moniae has been implicated as a possible cause of
atherosclerosis and atheroma development by a va-
riety of clinical and epidemiological studies.41 Kol
et al.1 reported that both chlamydial and human
Hsp60 could cause induction of the proinflamma-
tory cytokine tumor necrosis factor-or and matrix
metalloproteinase, an enzyme key in the produc-
tion of thrombi dislodged from atheromatous
plaque. Chlamydial Hsp60 together with chlamyd-
ial LPS 4z,43 also have been shown to cause activa-
tion of human monocytes in ways that relate di-
rectly to atheroma development and progression.
One of the hallmarks of atheroma development is
the accumulation of foam cells in the intimal space.
Foam cells are macrophages that have stored high
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TABLE 2. Comparison of the magnitude of response as indicated by the amount of antigen-specific serum IgG
present by group and subgroup
Significantly greater serum antibody levels to
Group Hspl0 Hsp60 MOMP
Acutely infected women, compared to uninfected controls
Women with TFI, compared to uninfected controls
Do women with TFI have a greater level of response than acutely
infected women?
For EB+ patients only, do women with TFI have a greater level of
response than acutely infected women?
For EB- patients only, do women with TFI have a greater level of






aThe average amount of antigen-specific antibody present in the sera of each respective population was determined by ELISA. Significant differences
were determined by analysis of variance with Bonferroni posttests.
amounts of esterified cholesterol that can later be
released to the extracellular milieu and contribute
to the formation of the lipid core of the developing
atherosclerotic lesion. Chlamydial LPS can cause
foam cell development in the presence of low-
density lipoprotein (LDL), which appears to occur
in the absence of demonstrable LDL oxidative
modification.43 Another event that is key to ath-
eroma development is the oxidation of LDL and
other lipid-containing moieties at the site of lesion
progression. Low-density lipoprotein oxidation is
dramatically accelerated in the presence of C. pneu-
moniae, and recent data demonstrate that chlamyd-
ial Hsp60 can substitute for the intact organism in
promoting LDL oxidation. Interestingly, chlamyd-
ial Hspl0 was incapable of inducing oxidative
changes that resulted when macrophages were ex-
posed to Hsp60 in the presence of LDL. The in-
teraction between chlamydial LPS, Hsp60, and
known risk factors, such as elevated LDL, in the
pathogenesis of atherosclerosis is summarized in
Figure 1. It is reasonable to suppose that LDL
oxidation precedes foam cell development, since
large amounts of modified LDL can be taken up
via scavenger receptors present on the surface of
macrophages.44,4s This rationale is eminently sen-
sible in light of the knowledge that the LDL re-
ceptor that functions in the uptake of unmodified
LDL is tightly regulated in a negative feedback
loop by excess intracellular cholesterol.46 However,
in the presence of C. pneumoniae, chlamydial LPS,
or chlamydial Hsp60, the sequence of events, at
least in cell culture studies, suggest that LDL up-
take occurs prior to LDL oxidation, suggesting that
these two atherogenic events may not be directly
linked in a way that requires LDL oxidation for
foam cell development. This temporal scheme is
illustrated in Figure 2.
SUMMARY
The intent of this report is to provide some per-
spective on the ways in which hsps may contribute
to the disease process associated with various chla-
mydial infections. It is clear that severe pathologic
consequences are most frequently associated with
chronic rather than acute infections, and the poten-
tial for continuous elaboration of stress-response
proteins in the face of a low grade, persistent in-
fection would be predicted based on cell culture
analyses. It is noteworthy that this prediction has
been verified in several in vivo situations,s,s,l A
large body of data also has accumulated to suggest
that chlamydial stress-response proteins play a role
in the induction and development of diseases
caused by chlamydiae (e.g., these proceedings).
The continuous presence of chlamydial stress-
response proteins during chronic infection or as a
result of repeated infections over time can influ-
ence the disease process in at least three ways.
First, these proteins are antigenic. The immune
responses elicited may directly result in tissue
damage at the site of infection or may cause induc-
tion of cross-reactive immune responses involving
host hsp homologues and thus the induction of au-
toimmunity (see above). These two possibilities
should be further distinguishable by continued
careful analysis of T- and B-cell epitopes involved
in eliciting cell-mediated responses and antibody
production. The third way in which chlamydial
stress-response proteins may participate in the dis-
ease process is by direct activation of mononuclear
phagocytes and other responsive cells. This inter-
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A proposed role for C. pneumoniae infection
in the pathogenesis of atherosclerosis
Risk Factor Link ----, Pathogenic Event Disease
LDL-
cholesterol
Oxidative Endothelial cell damage
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Fig. I. Chlamydia pneumoniae and atherosclerosis, Links between a known risk factor (elevated LDL), two possible chlamydial
virulence factors (LPS and Hsp60), and the disease process (foam cell formation and oxidative-mediated tissue damage).
A proposed role for C. pneumoniae infection












Fig. 2. Chlamydia pneumoniae and atherosclerosis. Temporal distinction between pathologic changes elicited by chlamydial
LPS (foam cell formation) and Hsp60 (LDL oxidation).
esting possibility has been referred to as immune
surveillance by Young and Elliot,47 and implies the
presence of hsp receptors on cells that are capable
of initiating signal transduction pathways. Indeed,
Garduno et al.48 recently described an Hsp60-
mediated invasion process for Legionella pneumo-
phila entry into HeLa cells. In this context it may
be significant that direct activation of macrophages
by chlamydial Hsp60 appears to cause induction of
matrix metalloproteinase1 and oxidation of LDL
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(described above). Additional disease promoting
activities of chlamydial stress-response proteins
will no doubt emerge from the study of a variety of
chronic chlamydial infections as details are discov-
ered concerning how these interesting proteins
function in ways that promote disease.
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